Skip to main content
Caplight Logo









Contro

Contro

Private
Cape TownHealthcare & Life Scienceshttps://zapmed.co.za

Last Round

Pre Seed

Nov 9, 2022

Total Funding Raised

$584,000

Company Overview

Contro operates in Healthcare & Life Sciences and is based in Cape Town. Its latest recorded funding round was a Pre Seed round in November 2022.

Contro is a healthtech company that provides an online prescription and delivery service for sexual health and confidence products.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Subscription Commerce, D2C Brands

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Contro Comparables

Compare Contro with similar companies based on industry and business-model similarity.

Contro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Get My Pill
84%
Zoie Health
84%
Online Doctor SA
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Contro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 9, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Contro Investors

Notable investors and investment history

Contro investors
InvestorRounds
Jozi AngelsPre Seed
WZ CapitalPre Seed
Plug and Play Tech CenterPre Seed
iCubed CapitalPre Seed
Investing in Innovation (i3) AfricaPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 276% MoM, reaching 6.2K.

  • Apr 8, 2026

    Monthly visitors grew 178% MoM, reaching 1.7K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Contro Filings

Explore SEC and related filing metadata, where available.

Contro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Contro's valuation, stock price, and market status.

Is Contro a public or private company?

Contro is a private company.

What is the current stock price of Contro?

Contro is a private company, so its shares have no public market price. Caplight tracks Contro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Contro worth (valuation)?

Valuation information for Contro is not publicly available.

Can I buy Contro stock?

Contro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Contro's last funding round?

Contro's most recent funding round was Pre Seed on November 9, 2022.

Who are the main investors in Contro?

Key investors in Contro include Jozi Angels, WZ Capital, Plug and Play Tech Center, iCubed Capital, Investing in Innovation (i3) Africa.

Will Contro IPO soon?

No public IPO plans have been announced for Contro.

How can I track Contro secondary market activity?

Caplight tracks bids, offers, and trades in Contro's shares on secondary markets.

Firmographic Details

HeadquartersCape Town
Employee Range3
Year Founded2021
Last FundingNov 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?